Novel approach: intranasal vaccination strategy targets Omicron COVID-19 variants

FHS
July 14, 2023
9:36 am

Researchers tested the efficacy of a two to three-dose intranasal (IN) regimen of the NDV-HXP-S vaccine.

SciSparc and Clearmind Medicine Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic-Based Treatments | Psychedelic Invest

The collaboration included six different provisional patent applications filed by Clearmind with the United States Patent and Trademark Office in February 2023 to protect the

January 4, 2024

The Mediterranean Diet may be able to improve your sleep

Researchers review the associations between following a Mediterranean diet and sleep quality.

January 22, 2024

Cleveland Clinic study reveals kidney microbiome’s role in renal health

Cleveland Clinic researchers have found definitive proof of a kidney microbiome that influences renal health and kidney stone formation, demonstrating that the urinary tract is

December 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.